Assessment of scatter compensation strategies for (67)Ga SPECT using numerical observers and human LROC studies.

67Ga citrate is an oncologic SPECT imaging agent often used to diagnose or stage patients with non-Hodgkin's lymphoma. As (67)Ga decay involves the emission of multiple-energy gamma-rays, significant photon downscatter will be present within each photopeak energy window. We have previously shown that the inclusion of these scattered photons significantly degrades lesion detectability. The goal of this study was to investigate the extent to …